VivoSeq
Other

Magnesium Sulfate

0

Pipeline Programs

9

Active Trials

0

Companies Involved

Magnesium Sulfate is an early-stage landscape with 0 programs across 0 companies.

Pipeline Metrics

Competitive Density

25/100

Pipeline Velocity

15/100

Mech. Concentration

N/A

Completion Rate

88/100

Attrition Rate

7/100

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

55

clinical trials

Completed30 · 55%
Unknown status12 · 22%
Not yet recruiting6 · 11%
Terminated3 · 5%
Recruiting2 · 4%
Active, not recruiting1 · 2%
Other1 · 2%

Trial Activity

55 trials

Magnesium Sulfate as an Adjunctive Analgesic in Prostate Surgery
Active, not recruiting·NNYU Langone Health·Phase 4·NCT06477133·68 enrolled
Magnesium Sulfate in Neonatal HIE"
Not yet recruiting··Phase 4·NCT06342362·102 enrolled
Magnesium Sulfate and Trigger Points
Not yet recruiting·FFayoum University·Phase 2·NCT06975813·30 enrolled
Dexmedetomidine Versus Magnesium Sulfate Infusion in Craniotomy
Not yet recruiting··N/A·NCT07199595·60 enrolled
Page 1 of 4

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)